Point72 Hong Kong LTD Karuna Therapeutics, Inc. Transaction History

Point72 Hong Kong LTD

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$123.79 - $277.42 $42,707 - $95,709	345 New	345 $78,000
Q2 2022 Aug 15, 2022	SELL	$93.97 - $143.33 $16,256 - $24,796	-173 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$98.9 - $132.37 $58,449 - $78,230	-591 Reduced 77.36%	173 $22,000
Q4 2021 Feb 14, 2022	BUY	$110.64 - $159.4 $71,473 - $102,972	646 Added 547.46%	764 $100,000
Q3 2021 Nov 15, 2021	SELL	$101.2 - $125.87 $82,882 - $103,087	-819 Reduced 87.41%	118 $14,000
Q2 2021 Aug 16, 2021	BUY	$107.45 - $135.95 $83,918 - $106,176	781 Added 500.64%	937 $107,000
Q1 2021 May 17, 2021	BUY	$95.46 - $133.08 $14,891 - $20,760	156 New	156 $19,000
Q4 2020 Feb 16, 2021	SELL	$75.23 - $109.23 $81,022 - $117,640	-1,077 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$71.31 - $109.74 $71,452 - $109,959	1,002 Added 1336.0%	1,077 $83,000
Q2 2020 Aug 14, 2020	BUY	$62.14 - $117.21 $4,660 - $8,790	75 New	75 $8,000

332K

Ticker KRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,965,000
Description
Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

Stay updated on Point72 Hong Kong LTD with notifications on news.